Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search for new targets for an effective therapy of neuropathic pain and enhancement of opioids effects basing on the examination and modulation of changes in chemokine systems.

2016/21/B/NZ4/00128

Keywords:

neuropathic pain chemokines neuroimmunology microglia analgesic drugs

Descriptors:

  • NZ4_4: Pathophysiology
  • NZ4_7: Neurophysiology
  • NZ4_12: Other related subjects

Panel:

NZ4 - Biology of tissues, organs and organisms: morphology and functions of animal's and human's systems, organs and organisms, experimental medicine, basics of neurology

Host institution :

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

woj. małopolskie

Other projects carried out by the institution 

Principal investigator (from the host institution):

prof. Joanna Mika 

Number of co-investigators in the project: 6

Call: OPUS 11 - announced on 2016-03-15

Amount awarded: 1 307 830 PLN

Project start date (Y-m-d): 2017-02-13

Project end date (Y-m-d): 2022-02-12

Project duration:: 60 months (the same as in the proposal)

Project status: Project settled

Project description

Download the project description in a pdf file

Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Equipment purchased [PL]

  1. Automatyczny wielodetekcyjny czytnik SPARK M10 firmy TECAN Austria (158 118 PLN)
  2. Inkubator do hodowli komórkowych.
  3. Mikroscop odwrócony.

Information in the final report

  • Publication in academic press/journals (23)
  • Articles in post-conference publications (42)
  1. Bidirectional action of cenicriviroc, a CCR2/CCR5 antagonist, results in alleviation of pain-related behaviors and potentiation of opioid analgesia in rats with peripheral neuropathy.
    Authors:
    Kwiatkowski K., Pawlik K., Ciapała K., Piotrowska A., Makuch W., Mika J.
    Academic press:
    Front. Immunol. (rok: 2020, tom: 11, strony: 615327(1-16)), Wydawca: Frontiers Media SA
    Status:
    Published
    DOI:
    10.3389/fimmu.2020.615327 - link to the publication
  2. Blockade of CC chemokine receptor type 3 diminishes pain and enhances opioid analgesic potency in a model of neuropathic pain
    Authors:
    Pawlik K., Ciechanowska A., Ciapała K., Rojewska E., Makuch W., Mika J.
    Academic press:
    Front. Immunol. (rok: 2021, tom: 12, strony: 781310 (1-20)), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.3389/fimmu.2021.781310 - link to the publication
  3. Chemokines CCL2 and CCL7, but not CCL12, play a significant role in the development of pain-related behavior and opioid-induced analgesia.
    Authors:
    Kwiatkowski K, Popiolek-Barczyk K, Piotrowska A, Rojewska E, Ciapała K, Makuch W, Mika J.
    Academic press:
    Cytokine (rok: 2019, tom: 16, strony: 202-213), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.cyto.2019.03.007 - link to the publication
  4. Comparison of the effects of chemokine receptors CXCR2 and CXCR3. Pharmacological modulation in neuropathic pain model – in vivo and in vitro study
    Authors:
    Piotrowska A., Ciapała K., Pawlik K., Kwiatkowski K., Rojewska E., Mika J.
    Academic press:
    Int J Mol Sci. (rok: 2021, tom: 22, strony: 11074 (1-24)), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/ijms222011074 - link to the publication
  5. Kynurenic acid and zaprinast diminished CXCL17-evoked pain-related behaviour and enhanced morphine analgesia in a mouse neuropathic pain model.
    Authors:
    Rojewska E, Ciapała K, Mika J.
    Academic press:
    Pharmacol Rep. (rok: 2019, tom: 71(1), strony: 139-148), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.002 - link to the publication
  6. Lipopolysaccharide from Rhodobacter sphaeroides (TLR4 antagonist) attenuates hypersensitivity and modulates nociceptive factors.
    Authors:
    Jurga AM., Rojewska E., Makuch W., Mika J.
    Academic press:
    Pharmaceutical Biology (rok: 2018, tom: 56 (1), strony: 275-286), Wydawca: Taylor&Francis Group
    Status:
    Published
    DOI:
    10.1080/13880209.2018.1457061 - link to the publication
  7. Pharmacological blockade of CXCR3 by (±)-NBI-74330 reduces neuropathic pain and enhances opioid effectiveness - Evidence from in vivo and in vitro studies.
    Authors:
    Piotrowska A., Rojewska E., Pawlik K., Kreiner G., Ciechanowska A., Makuch W., Zychowska M, Mika J.
    Academic press:
    Biochimica et Biophysica Acta - Molecular Basis of Disease (rok: 2018, tom: 1864, strony: 3418-3437), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.bbadis.2018.07.032 - link to the publication
  8. The RS504393 influences the level of nociceptive factors and enhances opioid analgesic potency in neuropathic rats
    Authors:
    Kwiatkowski K., Piotrowska A., Rojewska E., Makuch W., Mika J.
    Academic press:
    J Neuroimmune Pharmacol (rok: 2017, tom: 12, strony: 402-419), Wydawca: Springer
    Status:
    Published
    DOI:
    10.1007/s11481-017-9729-6 - link to the publication
  9. Metamizol relieves pain by influencing the cytokine levels in the dorsal root ganglia in a rat model of neuropathic pain
    Authors:
    Zajaczkowska R., Kwiatkowski K., Pawlik K., Piotrowska A., Rojewska E., Makuch W., Wordliczek J., Mika J.
    Academic press:
    Pharmacol. Rep. (rok: 2020, tom: 72(5), strony: 1310-1322), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1007/s43440-020-00137-8 - link to the publication
  10. The importance of chemokines in neuropathic pain development and opioid analgesic potency
    Authors:
    Kwiatkowski K., Mika J.
    Academic press:
    Pharmacological Reports (rok: 2018, tom: 70, strony: 821-30), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.pharep.2018.01.006 - link to the publication
  11. CCR4 antagonist (C021) administration diminishes hypersensitivity and enhances the analgesic potency of morphine and buprenorphine in mouse model of neuropathic pain
    Authors:
    Bogacka J., Ciapala K., Pawlik K., Kwiatkowski K., Dobrogowski J., Przeklasa-Muszyńska A., Mika J.
    Academic press:
    Front. Immunol. (rok: 2020, tom: 11, strony: 1241(1-17)), Wydawca: Frontiers Media SA
    Status:
    Published
    DOI:
    10.3389/fimmu.2020.01241 - link to the publication
  12. Blockade of CCR4 diminishes hypersensitivity and enhances opioid analgesia - evidence from a mouse model of diabetic neuropathy
    Authors:
    Bogacka J., Ciapała K., Pawlik K., Dobrogowski J., Przeklasa-Muszynska A., Mika J.
    Academic press:
    Neuroscience (rok: 2020, tom: 441, strony: 77-92), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.neuroscience.2020.06.025 - link to the publication
  13. CCR4 antagonist (C021) influences the level of nociceptive factors and enhances the analgesic potency of morphine in a rat model of neuropathic pain.
    Authors:
    Bogacka J., Popiolek-Barczyk K., Pawlik K., Ciechanowska A., Makuch W., Rojewska E., Dobrogowski J., Przeklasa-Muszynska A., Mika J.
    Academic press:
    Eur. J. Pharmacol. (rok: 2020, tom: 880, strony: 173166 (1-10)), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.ejphar.2020.173166 - link to the publication
  14. Comparison of the expression changes after Botulinum toxin type A and minocycline administration in lipopolysaccharide-stimulated rat microglial and astroglial cultures
    Authors:
    Piotrowska A., Popiolek-Barczyk K., Pavone F., Mika J
    Academic press:
    Frontiers in Cellular and Infection Microbiology (rok: 2017, tom: 7, strony: 45308), Wydawca: Frontiers
    Status:
    Published
    DOI:
    10.3389/fcimb.2017.00141 - link to the publication
  15. Dataset of (±)-NBI-74330 (CXCR3 antagonist) influence on chemokines under neuropathic pain
    Authors:
    Piotrowska A., Rojewska E., Pawlik K., Kreiner G., Ciechanowska A., Makuch W., Mika J.
    Academic press:
    Data in Brief (rok: 2018, tom: 21, strony: 1145–1150), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.091 - link to the publication
  16. Pharmacological Blockade of Spinal CXCL3/CXCR2 Signaling by NVP CXCR2 20, a Selective CXCR2 Antagonist, Reduces Neuropathic Pain Following Peripheral Nerve Injury
    Authors:
    Piotrowska A., Rojewska E., Pawlik K., Kreiner G., Ciechanowska A., Makuch W., Nalepa I, Mika J.
    Academic press:
    Frontiers in Immunology (rok: 2019, tom: 10, strony: 45313), Wydawca: Frontiers
    Status:
    Published
    DOI:
    10.3389/fimmu.2019.02198 - link to the publication
  17. Ból neuropatyczny: etiologia, patomechanizm, implikacje kliniczne wynikające z badań podstawowych
    Authors:
    Kwiatkowski K., Mika J.
    Academic press:
    Problemy Edukacji, Rehabilitacji i Socjalizacji Osób Niepełnosprawnych (rok: 2017, tom: 25(2/2017), strony: 113-125), Wydawca: Wydawnictwo Uniwersytetu Śląskiego, Katowice
    Status:
    Published
    DOI:
    - - link to the publication
  18. Comparison of the beneficial effects of RS504393, maraviroc and cenicriviroc on neuropathic pain-related symptoms in rodents: behavioral and biochemical analyses
    Authors:
    Kwiatkowski K. Ciapała K., Rojewska E., Makuch W., Mika J.
    Academic press:
    Int Immunopharmacol. (rok: 2020, tom: 84, strony: 106540 (1-12)), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.intimp.2020.106540 - link to the publication
  19. Involvement of macrophage inflammatory protein-1 (MIP-1) family members in the development of diabetic neuropathy and their contribution to effectiveness of morphine
    Authors:
    Rojewska E., Zychowska M., Piotrowska A., Kreiner G., Nalepa I., Mika J.
    Academic press:
    Frontiers in Immunology (rok: 2018, tom: 9, strony: 21), Wydawca: Frontiers
    Status:
    Published
    DOI:
    10.3389/fimmu.2018.00494/abstract - link to the publication
  20. Involvement of microglial cells in the antinociceptive effects of metamizol in a mouse model of neuropathic pain
    Authors:
    Zajaczkowska R., Popiolek- Barczyk K., Pilat D., Rojewska E., Makuch W., Wordliczek J., Mika J.
    Academic press:
    Pharmacology Biochemistry and Behavior (rok: 2018, tom: 175, strony: 77-78), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.pbb.2018.09.008 - link to the publication
  21. Spinal CCL1/CCR8 signaling interplay as a potential therapeutic target – evidence from a mouse diabetic neuropathy model
    Authors:
    Zychowska M., Rojewska E., Piotrowska A., Kreiner G., Nalepa I., Mika J.
    Academic press:
    International Immunopharmacology (rok: 2017, tom: 52, strony: 261–271), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.intimp.2017.09.021 - link to the publication
  22. Tapentadol – A representative of a new class of MOR-NRI analgesics
    Authors:
    Zajaczkowska R., Przewlocka B., Kocot- Kępska M., Mika J., Leppert W., Wordliczek J.
    Academic press:
    Pharmacological Reports (rok: 2018, tom: 70, strony: 812-820), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.pharep.2018.01.005 - link to the publication
  23. The blockade of CC chemokine receptor type 1 influences the level of nociceptive factors and enhances opioid analgesic potency in a rat model of neuropathic pain
    Authors:
    Pawlik K., Piotrowska A., Kwiatkowski K., Ciapała K., Popiolek-Barczyk K., Makuch W., Mika J.
    Academic press:
    Immunology (rok: 2020, tom: 159(4), strony: 413-428), Wydawca: Wiley
    Status:
    Published
    DOI:
    10.1111/imm.13172 - link to the publication
  1. A new antagonists of H3R as a potential neuropathic painkillers
    Authors:
    Popiolek-Barczyk K., Łazewska D., Latacz G., Olejarz A., Stark H., Makuch W., Kieć-Kononowicz K., Mika J.
    Conference:
    European Pain Federation Krakow Pain School, EFIC School 2019, Translational Pain Research "From Lab to clinic" (rok: 2019, ), Wydawca: Index Copernicus International
    Data:
    konferencja 22-27.06.
    Status:
    Published
  2. Antagonism of histamine H3 receptor reduced neuropathic pain in mice and enhanced morphine analgesia.
    Authors:
    Popiolek-Barczyk K, Łażewska D, Latacz G, Olejarz A, Makuch W., Piotrowska A., Kieć- Kononowicz K., Mika JW., Mika J.
    Conference:
    3rd Central European Biomedical Congress (rok: 2018, ), Wydawca: CEBC, Kraków 2018
    Data:
    konferencja 15-18.09.2018
    Status:
    Published
  3. Czy leki antyretrowirusowe mogą działać przeciwbólowo? Rola CCR5 w bólu neuropatycznym.
    Authors:
    Kwiatkowski K., Ciapała K., Popiolek-Barczyk K., Piotrowska A., Makuch W., Mika J.
    Conference:
    X Zjazd Polskiego Towarzystwa Badania Bólu – MEDYCYNA BÓLU 2019 (rok: 2019, ), Wydawca: Index Copernicus International
    Data:
    konferencja 26-28-09.
    Status:
    Published
  4. Plerixafor osłabia rozwój bólu neuropatycznego u szczurów poprzez modulację endogennych czynników pronocyceptywnych
    Authors:
    Kwiatkowski K., Rojewska E., Piotrowska A., Makuch W., Mika J.
    Conference:
    Europejska Szkoła Bólu w Krakowie (rok: 2017, ), Wydawca: Index Copernicus
    Data:
    konferencja 25-29.06.2017
    Status:
    Published
  5. Wpływ modulatorów szlaków wewnątrzkomórkowych - peiminy i fisetyny - na nocycepcję oraz efektywność opioidów w mysim modelu bólu neuropatycznego
    Authors:
    Ciapała K, Rojewska E, Pawlik K, Mika J
    Conference:
    XXXIX SZKOŁA ZIMOWA Instytutu Farmakologii im. Jerzego Maja PAN "Dysfunkcje metaboliczne a choroby ośrodkowego układu nerwowego" (rok: 2022, ), Wydawca: IF PAN
    Data:
    konferencja 2-4.03.2022, Kraków
    Status:
    Published
  6. Blockade of CXCR2 inhibits neuropathic pain – related behavior and modulates primary microglial and astroglia culture.
    Authors:
    Pawlik K., Piotrowska A., Rojewska E., Ciechanowska A., Makuch W., Mika J.
    Conference:
    European Meeting on Glial Cells in Health and Disease (rok: 2019, ), Wydawca: Wiley Online Library
    Data:
    konferencja 10-13.07
    Status:
    Published
  7. Fisetin, a plant-derived flavonoid as a new promising tool in neuropathic pain management – evidences from behavioral studies in mice
    Authors:
    Ciapała K., Rojewska E., Mika J.
    Conference:
    4th Central European Biomedical Congress "The impact of bioinformatics and omics on biology and medicine" (rok: 2021, ), Wydawca: IF PAN, Kraków
    Data:
    konferencja 7-9.06.2021
    Status:
    Published
  8. Importance of CCL17/CCL22/CCR4 signaling in nociceptive transmission and morphine analgesic potency in naïve and neuropathic animals
    Authors:
    Kujacz J., Popiołek-Barczyk K., Makuch W., Ciechanowska A., Dobrogowski J., Przeklasa-Muszynska A., J Mika J.
    Conference:
    Pain in Europe XI, 11th Congress of the European Pain Federation EFIC, Walencja, Hiszpania (rok: 2019, ), Wydawca: EFIC
    Data:
    konferencja 4-7.09.
    Status:
    Published
  9. Involvement of chemokines CCL2 and CCL7 in pathogenesis of neuropathic pain in mice.
    Authors:
    Kwiatkowski K., Popiolek-Barczyk K., Rojewska E., Makuch W., Mika J.
    Conference:
    European Pain Federation Krakow Pain School, EFIC School 2019, Translational Pain Research "From Lab to clinic" (rok: 2019, ), Wydawca: Index Copernicus International
    Data:
    konferencja 22-27.06.
    Status:
    Published
  10. Pharmacological blockade of CCR1 and CCR5 diminished neuropathic pain and enhanced morphine/buprenorphine effectiveness.
    Authors:
    Pawlik K., Piotrowska A., Kwiatkowski K., Ciapała K., Makuch W., Mika J.
    Conference:
    48th meeting of the European Histamine Research Society (rok: 2019, ), Wydawca: EHRS
    Data:
    konferencja 15-18.05
    Status:
    Published
  11. Significance of CCL17/CCL22/CCL2 signalling in nociceptive transmission and morphine analgesic potency
    Authors:
    Bogacka J., Ciapała K., Pawlik K., Kwiatkowski K., Dobrogowski J., Przeklasa-Muszynska A., Mika J.
    Conference:
    4th Central European Biomedical Congress "The impact of bioinformatics and omics on biology and medicine" (rok: 2021, ), Wydawca: IF PAN Kraków
    Data:
    konferencja 7-9.06.2021
    Status:
    Published
  12. Alterations in CCL2, CCL7 and CCL12 expression – studies in the model of Traumatic Brain Injury and glial cell cultures.
    Authors:
    Popiolek-Barczyk K., Ciechanowska A., Oggioni M., Mercurio D., Ippati S., Piotrowska A. Kwiatkowski K., De Simoni Mg., Mika J.
    Conference:
    European Meeting on Glial Cells in Health and Disease (rok: 2019, ), Wydawca: Wiley Online Library
    Data:
    konferencja 10-13.07.
    Status:
    Published
  13. Antinociceptive effects of novel histamine H3R receptor antagonist, E-162, and its influence on morphine analgesia of neuropathic pain in the mouse.
    Authors:
    Popiołek-Barczyk K., Łażewska D., Latacz G., Makuch W., Piotrowska A., Kieć-Kononowicz K., Mika J.
    Conference:
    Neuronus 2018 (rok: 2018, ), Wydawca: Neuronus IBRO NEUROSCIENCE FORUM
    Data:
    konferencja 20-22.04.2018 Krakow
    Status:
    Published
  14. Blockade of CCR4 receptor diminishes the level of nociceptive factors and potentiates morphine analgesia in a rat model of neuropathic pain.
    Authors:
    Kujacz J., Popiolek-Barczyk K., Makuch W., Ciechanowska A., Rojewska E., Dobrogowski J., Przeklasa-Muszyńska A., Mika J.
    Conference:
    European Pain Federation Krakow Pain School, EFIC School 2019, Translational Pain Research "From Lab to clinic" (rok: 2019, ), Wydawca: Index Copernicus International
    Data:
    konferencja 22-27.06.
    Status:
    Published
  15. J113863 and maraviroc reduce neuropathic pain and enhance opioid effectiveness.
    Authors:
    Pawlik K., Piotrowska A., Kwiatkowski K. Ciapala K., Makuch W., Mika J.
    Conference:
    European Pain Federation Krakow Pain School, EFIC School 2019, Translational Pain Research "From Lab to clinic" (rok: 2019, ), Wydawca: Index Copernicus International
    Data:
    konferencja 22-27-.06.
    Status:
    Published
  16. Parthenolide attenuates neuropathic pain symptoms and enhances morphine analgesia in animal model of neuropathy.
    Authors:
    Ciechanowska A., Popiołek-Barczyk K, Ciapała K., Makuch W., Mika J.
    Conference:
    48th meeting of the European Histamine Research Society (rok: 2019, ), Wydawca: EHRS
    Data:
    konferencja 15-18.05
    Status:
    Published
  17. Pharmacological kynurenine 3-monooxygenase enzyme Inhibition by UPF-648 significantly reduces neuropathic pain and enhanced opioid analgesia in a rat model.
    Authors:
    Ciapała K., Rojewska E., Piotrowska A., Pawlik K., Makuch W., Mika J.
    Conference:
    48th meeting of the European Histamine Research Society (rok: 2019, ), Wydawca: EHRS
    Data:
    konferencja 15-18.05
    Status:
    Published
  18. The role of selected endogenous ligands of CCR2 in neuropathic pain-related behaviors in mice.
    Authors:
    Kwiatkowski K., Popiołek- Barczyk K., Rojewska E., Żychowska M., Mika J.
    Conference:
    Neuronus 2018 (rok: 2018, ), Wydawca: Neuronus IBRO NEUROSCIENCE FORUM
    Data:
    konferencja 20-22.04.2018 Krakow
    Status:
    Published
  19. Antinociceptive effects of novel histamine H3R receptor antagonist in mouse model of neuropathic pain
    Authors:
    Popiołek Barczyk K., Łażewska D., Latacz G., Makuch W., Rojewska E., Kieć-Kononowicz K., Mika J
    Conference:
    Neurochemical Conference Advances in molecular and epigenetic mechanisms in neurodegeneration and neuroinflammation: novel therapeutic approaches" (rok: 2017, ), Wydawca: Warszawa IMDIK PAN
    Data:
    konferencja 19-20.10.2017
    Status:
    Published
  20. Antinociceptive effects of pharmacological kynurenine-3-monooxygenase inhibition by UPF-648 and its influence on opioids effectiveness in neuropathic rats
    Authors:
    Ciapala K., Rojewska E., Piotrowska A., Pawlik K., Makuch W., Mika J.
    Conference:
    European Pain Federation Krakow Pain School, EFIC School 2019, Translational Pain Research "From Lab to clinic" (rok: 2019, ), Wydawca: Index Copernicus International
    Data:
    konferencja 22-27.06.
    Status:
    Published
  21. Comparison of analgesic effects of maraviroc, RS504393 and cenicriviroc in rodents after sciatic nerve injury based on behavioral and molecular studies.
    Authors:
    Kwiatkowski K., Ciapała K., Popiołek-Barczyk K., Makuch W., Mika J.
    Conference:
    Pain in Europe XI, 11th Congress of the European Pain Federation EFIC, Walencja, Hiszpania (rok: 2019, ), Wydawca: EFIC
    Data:
    konferencja 4-7.09
    Status:
    Published
  22. Comparison of pharmacological modulation of glial cells by the CCR5 and CXCR3 receptor antagonists –in vivo and in vitro studies.
    Authors:
    Piotrowska-Murzyn A., Kwiatkowski K., Rojewska E., Pawlik K., Ciechanowska A., Mika J.
    Conference:
    European Meeting on Glial Cells in Health and Disease (rok: 2019, ), Wydawca: Wiley Online Library
    Data:
    konferencja 10-13.07
    Status:
    Published
  23. Effect of botulinum toxin type A and minocycline on lipopolysaccharide-stimulated rat microglial and astroglial cultures
    Authors:
    Piotrowska-Murzyn A., Popiołek Barczyk K., Pavone F., Mika J.
    Conference:
    XII European Meeting on Glial Cells in Health and Disease (rok: 2017, ), Wydawca: GLIA
    Data:
    konferencja 08-11.07.2017
    Status:
    Published
  24. Modulacja CCR1 i CCR3 obniża symptomy bólu neuropatycznego poprzez wpływ na aktywację mikrogleju i neutrofili
    Authors:
    Pawlik-Szczerba K, Ciechanowska A, Makuch W, Mika J.
    Conference:
    XXXIX SZKOŁA ZIMOWA Instytutu Farmakologii im. Jerzego Maja PAN "Dysfunkcje metaboliczne a choroby ośrodkowego układu nerwowego" (rok: 2022, ), Wydawca: IF PAN
    Data:
    konferencja 2-4.03.2022, Kraków
    Status:
    Published
  25. Molecular patterns of XCL1 and its receptors after central and peripheral nervous system damages
    Authors:
    Ciechanowska A., Pawlik K., Ciapała K., Oggioni M., Mercurio D., De Simoni M.G., Mika J.
    Conference:
    4th Central European Biomedical Congress "The impact of bioinformatics and omics on biology and medicine" (rok: 2021, ), Wydawca: IF PAN Kraków
    Data:
    konferencja 7-9.06.2021
    Status:
    Published
  26. Pharmacological blockade of CXCR3 by (±)-NBI-74330 reduces neuropathic pain.
    Authors:
    Pawlik K., Piotrowska A., Rojewska E., Ciechanowska A., Makuch W., Mika J.
    Conference:
    3rd Central European Biomedical Congress (rok: 2018, ), Wydawca: CEBC, Krakow 2018
    Data:
    konferencja 15-18.09.2018 Krakow
    Status:
    Published
  27. Pharmacological modulation of glia attenuate neuropathic pain and enhance opioid effectiveness
    Authors:
    Mika J.
    Conference:
    48th meeting of the European Histamine Research Society (rok: 2019, ), Wydawca: EHRS
    Data:
    konferencja 15-18.05
    Status:
    Published
  28. The (±)-NBI-74330 (CXCR3 antagonist) reduces neuropathic pain and influences the level of nociceptive factors – evidence from in vivo and in vitro studies
    Authors:
    Pawlik K., Piotrowska A., Rojewska E., Popiołek- Barczyk K., Mika J.
    Conference:
    Neuronus 2018 (rok: 2018, ), Wydawca: Neuronus IBRO NEUROSCIENCE FORUM
    Data:
    konferencja 20-22.04.2018 Krakow
    Status:
    Published
  29. The antagonist of CCR4 antagonist (C021) influence level of spinal nociceptive factors and enhances morphine analgesic potency in a rat neuropathic pain
    Authors:
    Kujacz J., Popiołek-Barczyk K., Makuch W., Ciechanowska A., Rojewska E., Dobrogowski J., Przeklasa-Muszynska A., Mika J.
    Conference:
    48th meeting of the European Histamine Research Society (rok: 2019, ), Wydawca: EHRS
    Data:
    konferencja 15-18.05
    Status:
    Published
  30. The dual CCR2/CCR5 antagonist, Cenicriviroc, attenuated neuropathic pain-related behavior and enhanced morphine effectiveness.
    Authors:
    Ciapała K., Kwiatkowski K., Makuch W., Mika J.
    Conference:
    Pain in Europe XI, 11th Congress of the European Pain Federation EFIC, Walencja, Hiszpania (rok: 2019, ), Wydawca: EFIC
    Data:
    konferencja 4-7.09.
    Status:
    Published
  31. The importance of C021 (CCR4 antagonist) in the development of pain-related behavior and opioid-induced analgesia.
    Authors:
    Bogacka J., Ciapała K., Pawlik K., Kwiatkowski K., Dobrogowski J., Przeklasa-Muszynska A., Mika J.
    Conference:
    Neuronus IBRO NEUROSCIENCE FORUM (rok: 2020, ), Wydawca: IBRO
    Data:
    konferencja 8-11.12.2020
    Status:
    Published
  32. Wpływ farmakologicznej modulacji receptora histaminowego H3 na proces nocycepcji w bólu neuropatycznym.
    Authors:
    Popiołek-Barczyk K., Łażewska D., Ciechanowska A., Makuch W., Kieć- Kononowicz K., Mika J.
    Conference:
    VII SYMPOZJUM "POSTĘPY W LECZENIU BÓLU" (rok: 2018, ), Wydawca: INDEX COPERNICUS
    Data:
    konferencja 4-6.10.2018 Zakopane
    Status:
    Published
  33. Antagoniści receptorów chemokinowych jako modulatory komórek glejowych w bólu neuropatycznym.
    Authors:
    Piotrowska A., Rojewska E., Pawlik K., Kwiatkowski K., Ciechanowska A., Makuch W., Mika J.
    Conference:
    VII SYMPOZJUM "POSTĘPY W LECZENIU BÓLU" (rok: 2018, ), Wydawca: INDEX COPERNICUS
    Data:
    konferencja 4-6.10.2018 Zakopane
    Status:
    Published
  34. Antinociceptive effects of a novel histamine H3 receptor antagonists In mouse model of neuropathic pain.
    Authors:
    K. Popiolek-Barczyk , D. Łażewska, G. Latacz, A. Olejarz, H. Stark, W. Makuch, K. Kieć-Kononowicz, J. Mika.
    Conference:
    48th meeting of the European Histamine Research Society (rok: 2019, ), Wydawca: EHRS
    Data:
    konferencja 15-18.05
    Status:
    Published
  35. Blockade of CXCR3 by (±)-NBI-74330 inhibits neuropathic pain in rats by modulating release of CXCR3 ligands.
    Authors:
    Piotrowska A, Rojewska E, Zychowska M., Makuch W., Mika J.
    Conference:
    Neuronus 2018 (rok: 2018, ), Wydawca: Neuronus IBRO NEUROSCIENCE FORUM
    Data:
    konferencja 20-22.04.2018 Krakow
    Status:
    Published
  36. CCR1 and CCR3 antagonism brings beneficial effects in neuropathic pain by affecting microglia and neutrophils
    Authors:
    Pawlik K., Ciechanowska A., Makuch W., Mika J.
    Conference:
    4th Central European Biomedical Congress "The impact of bioinformatics and omics on biology and medicine" (rok: 2021, ), Wydawca: IF PAN Kraków
    Data:
    konferencja 7-9.06.2021
    Status:
    Published
  37. CXCR3 receptor as new target to treat neuropathic pain: efficacy of a receptor antagonist in in vitro and in vivo studies.
    Authors:
    Piotrowska A., Kwiatkowski K., Rojewska E., Pawlik K., Ciechanowska A., Mika J.
    Conference:
    European Pain Federation Krakow Pain School, EFIC School 2019, Translational Pain Research "From Lab to clinic" (rok: 2019, ), Wydawca: Index Copernicus International
    Data:
    konferencja 22-27.06.
    Status:
    Published
  38. Comparison of antinociceptive effects of CXCR2 and CXCR3 receptor antagonists and their influence on opioids analgesia of neuropathic pain model.
    Authors:
    Piotrowska A., Rojewska E., Pawlik K., Ciechanowska A., Makuch W., Mika J.
    Conference:
    Pain in Europe XI, 11th Congress of the European Pain Federation EFIC, Walencja, Hiszpania (rok: 2019, ), Wydawca: EFIC
    Data:
    konferencja 4-7.09
    Status:
    Published
  39. Direct and Indirect Pharmacomodulation of CC Chemokine Receptor 2 Activity Results in Neuropathic Pain Attenuation and Enhancement of Opioids-Induced Analgesia in Rodents
    Authors:
    Kwiatkowski K., Popiolek-Barczyk K., Piotrowska A., Rojewska E., Makuch W., Mika J.
    Conference:
    7th International Congress on Neuropathic Pain (NeuPSIG 2019) (rok: 2019, ), Wydawca: NeuPSIG
    Data:
    konferencja 9-11.05.
    Status:
    Published
  40. Parthenolide, an inhibitor of NF-kB pathway, has analgesic properties in rodent model of neuropathic pain.
    Authors:
    Ciechanowska A., Popiolek-Barczyk K., Ciapala K., Makuch W., Mika J.
    Conference:
    European Pain Federation Krakow Pain School, EFIC School 2019, Translational Pain Research "From Lab to clinic" (rok: 2019, ), Wydawca: Index Copernicus International
    Data:
    konferencja 22-27.06.
    Status:
    Published
  41. The importance of spinal CC chemokine ligands 2 and 7 in neuropathic pain development and opioids effectiveness
    Authors:
    Kwiatkowski K., Popiołek- Barczyk K., Rojewska E., Piotrowska A., Mika J.
    Conference:
    31st ENCP Congress (rok: 2018, ), Wydawca: ENCP
    Data:
    konferencja 6-9.10.2018 Barcelona, Hiszpania
    Status:
    Published
  42. Wpływ XCL1 na rozwój symptomów bólu neuropatycznego u myszy
    Authors:
    Ciechanowska A, Rojewska E, Piotrowska-Murzyn A, Pawlik K, Ciapała K, Mika J.
    Conference:
    XXXIX SZKOŁA ZIMOWA Instytutu Farmakologii im. Jerzego Maja PAN "Dysfunkcje metaboliczne a choroby ośrodkowego układu nerwowego" (rok: 2022, ), Wydawca: IF PAN
    Data:
    konferencja 2-4.03.2022, Kraków
    Status:
    Published

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy